Wildlife may harbor clinically important antimicrobial resistant (AMR) bacteria, but the role of wildlife in the epidemiology of AMR bacterial infections in humans is largely unknown. In this study, we aimed to assess dissemination of theblaKPC carbapenemase gene among humans and gulls in Alaska.
We performed whole genome sequencing to determine the genetic context ofblaKPC in bacterial isolates from all four human carbapenemase-producing Enterobacteriaceae (CPE) infections reported in Alaska between 2013–2018 and to compare sequences to seven previously reported CPE isolates from gull feces within the same region and time period.
Genomic analysis of CPE isolates suggested independent acquisition events among humans with no evidence for direct transmission ofblaKPC between people and gulls. However, some isolates shared conserved genetic elements surrounding blaKPC, suggesting possible exchange between species.
Our results highlight the genomic plasticity associated withblaKPC and demonstrate that sampling of wildlife may be useful for identifying clinically relevant antimicrobial resistance not observed through local passive surveillance in humans.
|Title||Genomic comparison of carbapenem-resistant Enterobacteriaceae from humans and gulls in Alaska|
|Authors||Christina Ahlstrom, Anna Frick, Catherine Pongratz, Kimberly Spink, Catherine Xavier, Jonas Bonnedahl, Andrew M. Ramey|
|Publication Subtype||Journal Article|
|Series Title||Journal of Global Antimicrobial Resistance|
|Record Source||USGS Publications Warehouse|
|USGS Organization||Alaska Science Center Biology WTEB|